AMI data for Genentech's TNKase

Results of DNA's ASSENT 3 open-label international trial in 6,095 heart acute myocardial infarction (AMI) patients showed that the combination

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE